Open AccessLIPIDEMIC PROFILE AND RENAL FUNCTION IN PATIENTS WITH A COMPENSATION IN TYPE 2 DIABETES MELLITUS IN A CORRECTION OF HYPERTENSION WITH ANTAGONISTS RECEPTOR ANGIOTENSIN II
Author(s) -
N. O. Pertseva
Publication year - 2014
Publication title -
problemi endokrinnoï patologìï
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.141
H-Index - 2
eISSN - 2518-1432
pISSN - 2227-4782
DOI - 10.21856/j-pep.2014.4.04
Subject(s) - microalbuminuria , medicine , endocrinology , blood pressure , diabetes mellitus , angiotensin converting enzyme , renal function , type 2 diabetes mellitus , cardiology
The object of this study was to determine the dynamics of change the degree of neuropathic and dyslipidemic disorders in patients with compensation of type 2 diabetes and arterial hypertension in the correction of blood pressure with the use of Angiotensin II receptor blockers during one year. Standard antihypertensive therapy in patients with hyperglycemia compensation during one year is accompanied by regression of microalbuminuria in 81.2 % of patients and significant decrease in the concentration of low-density lipoprotein cholesterol relative to original values. Using of Angiotensin II receptor blockers in patients with high-quality glycemic control provides regression of microalbuminuria in 86.5 % of patients and results in an effective reduction of low-density lipoprotein cholesterol from the 6th month of treatment.